Efficacy and safety of an alpha 7-nicotinic acetylcholine receptor agonist, VQW-765, in subjects with performance anxiety: randomised, double-blind, placebo-controlled trial.
| Publicado en: | British Journal of Psychiatry Vol. 227; no. 1; pp. 473 - 481 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Cambridge University Press
Jul2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=186787895&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 186787895 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00071250 1V6 jtl: British Journal of Psychiatry issn: 00071250 maglogo: N pubinfo: dt: Jul2025 vid: 227 iid: 1 pid: 15979 pub: Cambridge University Press artinfo: ui: 186787895 10.1192/bjp.2025.84 186787895 ppf: 473 ppct: 8 formats: tig: atl: Efficacy and safety of an alpha 7-nicotinic acetylcholine receptor agonist, VQW-765, in subjects with performance anxiety: randomised, double-blind, placebo-controlled trial. aug: au: He, Yunsheng Polymeropoulos, Christos M. Mohrman, Michael A. Truslow, Sunny O. Xiao, Changfu Wu, Yukun Birznieks, Gunther Polymeropoulos, Mihael H. affil: Vanda Pharmaceuticals, Washington, DC, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|